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ABSTRACT
A two-stage adaptive optimal design is an attractive option for increasing the efficiency of clinical
trials. In these designs, based on interim data, the locally optimal dose is chosen for further exploration,
which induces dependencies between data from the two stages. When the maximum likelihood
estimator (MLE) is used under nonlinear regression models with independent normal errors in a pilot
study where the first stage sample size is fixed, and the second stage sample size is large, the Fisher
information fails to normalize the estimator adequately asymptotically, because of dependencies. In
this situation, we present three alternative random information measures and show that they provide
better normalization of the MLE asymptotically. The performance of random information measures
is investigated in simulation studies, and the results suggest that the observed information performs
best when the sample size is small.
Keywords Adaptive optimal designs; Stable convergence; Random information measures; Generalized Cramér-Slutzky
theorem; Inference for stochastic processes.
1 Introduction
Two-stage designs are used for many purposes, including enrichment, sample size re-estimation and to modify
randomization probabilities to improve the efficiency and/or efficacy of estimators. All these procedures use accumulated
data to change the operation of the experimental design, which induces dependencies between the first and second stage
data. Our interest lies in the effects of such dependencies on inference at the end of a pilot study where the first stage
sample size is fixed, and the second stage sample size is large.
In two-stage enrichment designs, patients more likely to benefit from the treatment are identified based on data from
the first stage, and second stage trials are conducted in the identified subpopulation [e.g., Simon and Maitournam [24],
Ivanova and Tamura [11], Rosenblum and van der Laan [20], Trippa et al. [28], Zang and Guo [29]]. Two-stage sample
size re-estimation methods are conducted by revising the final sample size with parameter estimation from the first stage
[e.g., Stein [26], Proschan [18], Shih [23], Schwartz and Denne [21], Zhong et al. [30], Tarima et al. [27], Broberg and
Miller [3]]. In two-stage adaptive optimal designs, information from the first stage is used to estimate optimal treatment
assignment probabilities for the second stage [e.g., Haines et al. [7], Lane and Flournoy [13], Englert and Kieser [5],
Lane et al. [14], Shan et al. [22]].
Lane and Flournoy [13] studied asymptotic distributional properties of the maximum likelihood estimator for nonlinear
regression models with independent normal errors. In their study, they used the Fisher information to norm the score
function when taking limits, obtaining a limiting distribution for the maximum likelihood estimator that is a random
scale mixture of normal random variable. Use of this result requires knowledge of the distribution of the limiting scaling
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random variable. Lane and Flournoy found this distribution in the special case of an exponential mean function. But the
method used is not generalizable, and so their result is informative, but not generally useful in practice.
In their review paper on likelihood theory for stochastic processes, Barndorff-Nielsen and Sørensen [2] describe
conditions under which maximum likelihood estimators normed with the Fisher information converge to randomly
scaled mixture of normal distributions, as was the case in Lane and Flournoy [13]. Limiting random mixtures of
normal random variables also arise in Ivanova et al. [12], Ivanova and Flournoy [10], and May and Flournoy [16].
But Barndorff-Nielsen and Sørensen describe a solution to this problem. Namely, they describe how using a random
norming in lieu of the Fisher information can lead to a standard normal distribution instead.
This paper examines the use of random normings in a practical situation. In particular, we evaluate these alternative
random norms in the same context as in Lane and Flournoy [13] and Lane et al. [14], and show how to apply them to
obtain the more useful standard normal distribution. Then we compare the rates of convergence and efficiencies of the
different norming alternatives.
Accordingly, this paper is organized as follows. In Section 2, we present the model to be studied in this paper. In Section
3, we describe stable and mixing convergences, which are needed, and a generalized version of the Cramér-Slutzky
theorem. In Section 4, we present the main asymptotic results for maximum likelihood estimators with random
normings. We conduct simulation studies to compare the efficiencies obtained with these normings for exponential and
logistic models in Section 5.
2 The Model
Let {yij} be observations from a two-stage adaptive design, where ni is the number of observations and xi ∈ [a, b]
is the single-dose used for the ith stage, i = 1, 2. To avoid degenerate cases, we assume ni ≥ 1, i = 1, 2, and set
n = n1 + n2. We consider a general regression model with independent normal errors:
yij = η(xi, θ) + ij , ij ∼ N(0, σ2), (1)
where η(xi, θ) = E(yij |xi) is some (possibly) nonlinear mean function, twice differentiable by θ; x1 ∈ [a, b] is given;
and for simplicity, θ is a 1-dimensional parameter. In addition, adaptation is restricted to the choice of x2, and x2
depends on stage 1 data only through sufficient statistics from stage 1. More specifically, x2 = x2(y¯1) is a random
function, where y¯j = (y11 + · · ·+y1,nj )/nj . Define ui =
√
ni[y¯i−η(xi, θ)]/σ. Then u1 ∼ N(0, 1). But u2 = u2(y¯1).
As for u2, E[u2] = Ey¯1E[u2|y¯1] = 0 and V ar[u2] = Ey¯1E[u22|y¯1] = 1. But u2 is only N(0, 1) conditionally on y¯1.
Let θˆni denote maximum likelihood estimators of θ based on stage i data, i = 1, 2, and let θˆn denote the maximum
likelihood estimator of θ based on all n trials. Since maximum likelihood estimators (MLEs) are functions of sufficient
statistics, θˆn1 is a function of the first stage mean response y¯1, and both θˆn2 and θˆn are functions of (y¯1, y¯2).
Then the likelihood function is
Ln(θ|y11, . . . , y1,n1 , y21, . . . , y2,n2) = fn(y11, . . . , y1,n1 , y21, . . . , y2,n2 |θ)
= fn1(y11, . . . , y1,n1 |θ)fn2(y21, . . . , y2,n2 |θ, y11, . . . , y1,n1)
∝ exp
− 12σ2
n1∑
i=1
[y1,i − η(x1, θ)]2 − 12σ2
n2∑
j=1
[y2,j − η(x2, θ)]2

∝ exp{− n12σ2 [y¯1 − η(x1, θ)]2 − n22σ2 [(y¯2 − η(x2, θ)]2} .
Letting η˙(xi, θ) = ddθη(xi, θ), and η¨(xi, θ) =
d2
dθ2 η(xi, θ), the score function can be written as
Sn(θ) =
d
dθ logLn(θ) = n1σ2 [y¯1 − η(x1, θ)]η˙(x1, θ) + n2σ2 [y¯2 − η(x2, θ)]η˙(x2, θ).
3 Stable and Mixing Convergence
3.1 Motivation and Definitions
Let {Xn}n≥1 and X be real random variables defined on some probability space (Ω,F , P ), and let G ⊂ F be a
sub−σ−field. Given a sequence of random variables {Yn}n≥1, suppose one wants to obtain the limiting distribution of
the product of YnXn. If Yn converges in probability to a constant c, and Xn converges in distribution to X , then YnXn
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d→ cX as n→∞ by the Cramér-Slutzky theorem [[25]]. However, Lane and Flournoy [13] showed for model (1) that
if n1/n is small (and provided common regularity conditions with η˙ ≡ η˙(xi, θ) 6= 0, |η˙| <∞), then
√
n(θˆn − θ) ≈ UVn2 , (2)
where Vn2 = [y¯2 − η(x2, θ)] /(σ /
√
n2) ∼ Z for every n2, where Z ∼ N(0, 1); and U = σ[η˙(x2, θ)]−1 is
independent of Vn2 and Z. Since Equation (2) holds for all n2, it holds in the limit as n2 →∞ with n1 fixed. That is,√
n(θˆn − θ) d→ UZ as n2 → ∞ with n1 fixed and U independent of Z. But U is a random function of y¯1 that does
not converge to a constant when n1 is held fixed. So one cannot divide both sides of Equation (2) by U and apply the
classical Cramér-Slutzky theorem to obtain a N(0, 1) limit.
To obtain a standard normal limit instead of the normal mixture in Equation (2) requires a generalized version of the
Cramér-Slutzky theorem, which is given in Lemma 4.2 below. The generalized Cramér-Slutzky theorem requires the
concepts of stable and mixing convergence, which were introduced by Rényi [19]. So before proceeding, we recall
these concepts. A thorough description of stable and mixing convergence can be found in Häusler and Luschgy [9].
Let PE(·) = P ( · ∩ E)/P (E) denote the conditional probability given the event E. We say that {Xn} converges
G−stably to X as n→∞ if
(Xn)n≥1
d→ X under PE for every event E ∈ G with P (E) > 0. (3)
Stable convergence is stronger than convergence in distribution, but not as strong as convergence in probability. If X is
independent of G, then the limit is said to be mixing.
3.2 Stable Convergence Under Model (1).
Under model (1), Fn1 = σ(y¯1) is a sub σ−field of F = Fn1+n2 = σ(y¯1, y¯2). In Lemma 3.1, we show that the
convergence given in (2) is, in fact, stable convergence. In the context of Equation (3), take G = Fn1 .
Lemma 3.1. If η˙ 6= 0 and |η˙| < ∞ under model 1,√n(θˆn − θ) → UZ Fn1−stably with U independent of Z as
n2 →∞ while n1 is fixed.
Proof. Because of Equation (2) we only have to show that
UVn2 → UZ Fn1 − stably as n2 →∞ with n1 fixed. (*)
Let the event E ∈ Fn1 with P (E) > 0. By Fn1-measurability of U and independence of Vn2 and Fn1 and of Z andFn1 in combination with Vn2 ∼ Z, we have Vn2U ∼ ZU under PE for all n2. In particular,
UVn2
d→ UZ under PE as n2 →∞.
This proves (∗) in view of the definition of stable convergence in Equation (3)
4 Standard normal limits with random norming
4.1 Random Norms and Their Limits under Model (1)
Barndorff-Nielsen and Sørensen [2] describe random measures of information that can be used as norms for estimator
and test statistics, and sometimes yield a more useful limit (e.g., standard normal) for MLEs. Following Barndorff-
Nielsen and Sørensen [2], we call them the observed, incremental observed and incremental expected information
measures. In the two-stage setting, it not only makes sense to define increments in the log-likelihood between individual
subjects, but also between stages because sufficient statistics are stage-wise data summaries. We examine both.
First we formally define these, together with the expected (Fisher) information, and then we evaluate them under model
1:
1. The observed information is the negative derivative of the score function:
jn(θ) = −S˙n(θ).
Barndorff-Nielsen and Sørensen [2] and others have considered the observed information to be a standard with
which the other information measures are compared.
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2. The Fisher information is the variance of the score function. Assuming the integral and derivatives exist and
are interchangeable, it is given by
in(θ) ≡ V ar[Sn(θ)] = E[Sn(θ)]2 = E[−S˙n(θ)].
Efron and Hinkley [4] studied the trade-off between the observed and expected (Fisher) information. They
argue for using the observed information for data analysis after a study is completed, and they express a
preference for using the expected information to design an experiment. Barndorff-Nielsen and Sørensen [2]
state that “the difference (between the observed and expected information) is due, essentially, to the high
content of ancillary information carried by the observed information.” Pierce [17] and Firth [6] showed the
observed information is larger than the Fisher information by an amount Op(n−1/2).
To define the incremental information in general, suppose a study is conducted in K stages with nk
subjects in each stage, k = 1, . . . ,K. Then the log-likelihood can be written in increments as Sn(θ) =
d
dθ logLn(θ) =
∑n
i=1Di(θ) =
∑K
k=1Dk(θ), where Di(θ) = Si(θ) − Si−1(θ) is the ith subject-wise
increment and Dk(θ) = Sn1,...,nk(θ)− Sn1,...,nk−1(θ) is the kth stage-wise increment with S0(θ) ≡ 0.
3. The incremental expected information was introduced as the conditional variance by Lévy and Borel [15]
in an early version of the Martingale central limit theorem. Let Fi denote the history of the experiment up
through the trial for subject i, i = 1, . . . , n; and let F0 be the trivial field. Then Fi is a filtration of F , i.e.:
F0 ⊂ F1 ⊂ F2 · · · ⊂ Fn. Using subject-wise and stage-wise increments in Sn(θ), we obtain the subject-wise
and stage-wise incremental norms:
IDn (θ) =
n∑
i=1
Eθ[Di(θ)2|Fi−1]; IDn (θ) =
K∑
k=1
Eθ[Dk(θ)
2|Fnk−1 ].
The incremental expected information is also called the quadratic characteristic of the score martingale.
4. The incremental observed information is given by
JDn (θ) =
n∑
i=1
Di(θ)2; JDn (θ) =
K∑
k=1
Dk(θ)
2.
In the terminology of martingale theory, it is called the quadratic variation of the score martingale [e.g.,
Barndorff-Nielsen and Sørensen [2]] and squared variation [e.g., Hall and Heyde [8]]. Barndorff-Nielsen and
Sørensen show that use of the incremental observed information may improve the robustness of estimators.
It is common for the random information measures to converge to the Fisher information. However, there can be
substantial differences with small sample sizes. Note that only observed and expected information are defined solely in
terms of the likelihood function and its distribution law. The incremental observed and expected information require
knowledge of how the log-likelihood function increases from one subject or one stage to the next.
We now evaluate the random information norms that we will use to obtain standard normal limits for θˆ. Under model
(1), with K = 2, the observed information is
jn(θ) =
n1
σ2
[η˙(x1, θ)]
2 − n1
σ2
[y¯1 − η(x1, θ)] η¨(x1, θ) + n2
σ2
[η˙(x2, θ)]
2 − n2
σ2
[y¯2 − η(x2, θ)] η¨(x2, θ). (4)
The subject-wise and stage-wise incremental observed information are, respectively,
JDn (θ) =
n∑
i=1
[Di(θ)]2 =
n1∑
i=1
[yi − η(x1, θ)]2
σ4
[η˙(x1, θ)]
2 +
n∑
i=n1+1
[yi − η(x2, θ)]2
σ4
[η˙(x2, θ)]
2 (5)
and
JDn (θ) = [D1(θ)]
2 + [D2(θ)]
2 = n21
[y¯1 − η(x1, θ)]2
σ4
[η˙(x1, θ)]
2 + n22
[y¯2 − η(x2, θ)]2
σ4
[η˙(x2, θ)]
2. (6)
The subject-wise and stage-wise incremental expected information are the same:
IDn (θ) =
n1∑
i=1
Eθ[Di(θ)2|Fi−1] +
n∑
i=n1+1
Eθ[Di(θ)2|Fi−1]
=
n1∑
i=1
Eθ
{
(yi − η(x1, θ))2
σ4
[η˙(x1, θ)]
2|Fi−1
}
+
n∑
i=n1+1
Eθ
{
(yi − η(x2, θ))2
σ4
[η˙(x2, θ)]
2|Fi−1
}
=
n1
σ2
[η˙(x1, θ)]
2 +
n2
σ2
[η˙(x2, θ)]
2; (7)
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IDn (θ) = Eθ{D1(θ)2|F0}+ Eθ{D2(θ)2|Fn1}
= n21Eθ
{
[y¯1 − η(x1, θ)]2
σ4
[η˙(x1, θ)]
2|F0
}
+ n22Eθ
{
[y¯2 − η(x2, θ)]2
σ4
[η˙(x2, θ)]
2|Fn1
}
=
n1
σ2
[η˙(x1, θ)]
2 +
n2
σ2
[η˙(x2, θ)]
2. (8)
Lemma 4.1 provides convergence results for the random normings that are then used to obtain the desired standard
normal limit for θˆn.
Lemma 4.1. Under model (1), if |η| <∞ and |η˙| <∞, as n2 →∞ with n1 is fixed,
(1) n−1jn(θˆn)
p−→ U−2,
(2) n−1JDn (θˆn)
p−→ U−2,
(3) n−1JDn (θˆn)
d−→ U−2W,
(4) n−1IDn (θˆn) = n
−1IDn (θˆn)
p−→ U−2,
where U−2 ≡ [η˙(x2, θ)]2σ−2 and W ∼ χ2(1).
Proof. (1) The first two terms of equation (4) go to 0 when divided by n. Note in the forth term that
y¯2 − η(x2, θ) p−→ E[y2,j − η(x2, θ)] = Ey¯1{E[y2,j − η(x2, θ)|y¯1]} = 0, j = 1, . . . , n2,
by the weak law of large numbers. As n → ∞, n2/n → 1, and so jn(θ)/n p−→ [η˙(x2, θ)]2σ−2, and
jn(θˆn)/n
p−→ [η˙(x2, θ)]2σ−2 = U−2.
(2) The first term of equation (5) tends to 0 when divided by n. In the second term, by the weak law of large
numbers,
n∑
i=n1+1
[yi − η(x2, θ)]2/n2
σ2
p−→ 1
σ2
Ey¯1E
{
[yn1+1 − η(x2, θ)]2 | y¯1
}
= 1.
As n→∞, and n2/n→ 1, JDn (θ)/n p−→ [η˙(x2, θ)]2σ−2, and JDn (θˆn)/n p−→ [η˙(x2, θ)]2σ−2 = U−2.
(3) The first term of equation (6) goes to 0 when divided by n. In the second term,
√
n2[y¯2 − η(x2, θ)]/σ is
distributed as N(0, 1) for every n2, so n2[y¯2 − η(x2, θ)]2σ−2 ∼ χ2(1) as n2 → ∞. And [η˙(x2, θ)]2σ−2 is
independent of n2[y¯2 − η(x2, θ)]2σ−2. Therefore,
n−1JDn (θˆn)
d−→ [η˙(x2, θ)]2σ−2n2[y¯2 − η(x2, θ)]2σ−2 = U−2W
where W ∼ χ2(1) as n2 →∞ and n2/n→ 1.
(4) Again, the first term of equations (8) and (7) go to 0 when divided by n. As n → ∞, and n2/n → 1,
IDn (θ)/n = I
D
n (θ)/n
p−→ [η˙(x2, θ)]2σ−2, and evaluated at θ = θˆn, this limit is U−2.
4.2 The Generalized Cramér-Slutzky theorem and Its Application
Now we introduce the Generalized Cramér-Slutzky Theorem in order to obtain main theoretical results in Theorem
4.3, that is, to obtain standard normal limits for θˆn using random norms. According to Lemma 4.1, the observed
information jn(θ), the stage-wise and subject-wise incremental expected information IDn (θ), I
D
n (θ), and the subject-
wise incremental observed information JDn (θ) can be applied to normalize the MLE by the generalized Cramér-Slutzky
theorem, while the stage-wise incremental observed information JDn (θ) cannot.
Lemma 4.2. The Generalized Cramér-Slutzky Theorem [1] Suppose that Xn
d−→ X G − stably. Let g(x, y) be a
continuous function of two variables, if Yn
p−→ Y , where Y is a G-measurable random variable. Then
g(Xn, Yn)
d−→ g(X,Y ) G − stably.
5
A PREPRINT - MAY 24, 2019
Theorem 4.3. Under model (1),
jn(θˆn)
1/2(θˆn − θ) d−→ N(0, 1) (mixing),
JDn (θˆn)
1/2(θˆn − θ) d−→ N(0, 1) (mixing),
IDn (θˆn)
1/2(θˆn − θ) = IDn (θˆn)1/2(θˆn − θ) d−→ N(0, 1) (mixing),
as n2 →∞ with n1 fixed.
Proof. Defining g(x, y) = x
√
y, g(x, y) is continuous function of two variables when y > 0. Let Xn =
√
n(θˆn − θ)
and Yn = n−1jn(θˆn). Then Xn
d−→ UZ Fn1 − stably and Yn p−→ U−2. Because U−2 = [η˙(x2, θ)]2σ−2 > 0 a.s,√
Yn
p−→ U−1. Now by Lemma 4.2,
g(Xn, Yn) =
√
n(θˆn − θ)n−1/2jn(θˆn)1/2 = jn(θˆn)1/2(θˆn − θ) d−→ UZU−1 = Z Fn1 − stably.
Since Z is independent of Fn1 ,
jn(θˆn)
1/2(θˆn − θ) d−→ N(0, 1) (mixing).
Similarly,
JDn (θˆn)
1/2(θˆn − θ) d−→ N(0, 1) (mixing),
IDn (θˆn)
1/2(θˆn − θ) = IDn (θˆn)1/2(θˆn − θ) d−→ N(0, 1) (mixing).
5 Adaptive Optimal Design Examples
In this section, we apply Theorem 4.3 to normalize MLEs following an adaptive optimal design under logistic and
exponential (location and scale) regression models. Then we compare their tail probabilities and the difference between
cumulative distribution functions using random norms and the Fisher information. For all models, the dose in the first
stage is fixed at x1 = 2, while the dose for stage 2 is selected from the range x2 ∈ [a, b] = [0.25, 4] based on stage 1
data. The divergence of the MLE of θ to infinity necessitates restricting the search to some finite interval (θ, θ); for
simplicity throughout this section, we assume θ ∈ (0, 1/a). All simulations assume the true parameter θ = 1 and
known variance σ2 = 0.52.
The stage-two dose that maximizes the increase in information on the unknown parameter is
x2(θ) = arg max
x2∈[a,b]
1
n2
V ar(Sn − Sn1) = arg max
x2∈[a,b]
[η˙(x2, θ)]
2. (9)
The two-stage adaptive optimal design is ξA = {[w1, x1], [w2, xˆ2]}, where xˆ2 is selected adaptively as given by (9),
i.e.,
xˆ2 =
{
a if x2(θˆn1) ≤ a;
x2(θˆn1) if x2(θˆn1) ∈ [a, b];
b if x2(θˆn1) ≥ b;
and wi = ni/n. For each model, we evaluate the MLE norms’ performance for several fixed values of n1, including a
locally optimal stage 1 sample size [14]:
n∗1(θ) ≡ arg max
n1∈{1,...,n}
i(ξA, θ),
where the notation i(θ) ≡ i(ξA, θ) makes Fisher information’s dependence on the design explicit. To provide an ideal
benchmark, n∗1(θ) is evaluated at the true value of θ for all models. A practical method to approximate the locally
optimal stage 1 sample size is discussed by Lane et al. [14].
5.1 Logistic Regression Models
We explore the sample size needed to obtain the normal tail probabilities for the location parameter and scale parameter
logistic regression models, separately.
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5.1.1 The Logistic-Location Model
Consider the Logistic-Location Model with independent normal errors:
y = [1 + ex−θ]−1 + ,  ∼ N(0, σ2), x ∈ [a, b], −∞ < a < b <∞
Maximizing the first-stage likelihood function,
Ln1(θ|y11, . . . , y1,n1) ∝ exp
{− n12σ2 [y¯1 − (1 + ex1−θ)−1]2} ,
yields the MLE:
θˆn1 =
 x1 + logit(y¯1) if y¯1 ∈ [0, (1 + e
x−θ¯)−1],
0 if y¯1 ≤ 0,
θ¯ if y¯1 ≥ (1 + ex−θ¯)−1.
Adaptively selecting the second-stage dose to be
xˆ2 =
 θˆn1 if y¯1 ∈ [(1 + e
x−a)−1, (1 + ex−b)−1],
b if y¯1 ≥ (1 + ex−b)−1,
a if y¯1 ≤ (1 + ex−a)−1,
the likelihood given data from both stages is
Ln(θ|y11, . . . , y1,n1 , y21, . . . , y2,n2) ∝ exp
{
− n12σ2 [y¯1 − (1 + ex1−θ)−1]2 − n22σ2 [y¯2 − (1 + ex2(y¯1)−θ)−1]2
}
,
and the MLE based on all data is
θˆn =
 θ
′
n if θ
′
n ∈ (0, 1/a),
0 if θ
′
n ≤ 0,
1/a if θ
′
n ≥ 1/a,
where θ
′
n maximizes Ln(θ|y11, . . . , y1,n1 , y21, . . . , y2,n2). The average Fisher information given data from both stages
is
1
n
i(ξA, θ) =
1
σ2
{
w1(1 + e
x1−θ)−4e2(x1−θ) + w2pia(1 + ea−θ)−4e2(a−θ) + w2pib(1 + eb−θ)−4e2(b−θ)
+ w2Ey¯1
[
(1 + ex2−θ)−4e2(x2−θ)I((1 + ex2−a)−1 < y¯1 < (1 + ex2−b)−1)
]}
,
where pia = Φ{√n1[(1 + ex2−a)−1− (1 + ex2−θ)−1]/σ} and pib = 1−Φ{√n1[(1 + ex2−b)−1− (1 + ex2−θ)−1]/σ}
are the probabilities that xˆ2 falls on the boundaries a and b, respectively.
According to functions (4), (5) and (8), respectively, the observed information is
jn(θ) =
n1
σ2
(1 + ex1−θ)−4e2(x1−θ) − n1
σ2
[
y¯1 − (1 + ex1−θ)−1
]
(1 + ex1−θ)−3(ex1−θ − 1)
+
n2
σ2
(1 + ex2−θ)−4e2(x2−θ) − n2
σ2
[
y¯2 − (1 + ex2−θ)−1
]
(1 + ex2−θ)−3(ex2−θ − 1);
the subject-wise incremental observed information is
JDn (θ) =
n1∑
i=1
[yi − (1 + ex1−θ)−1]2
σ4
(1 + ex1−θ)−4e2(x1−θ) +
n∑
i=n1+1
[yi − (1 + ex2−θ)−1]2
σ4
(1 + ex2−θ)−4e2(x2−θ);
and the stage-wise and subject-wise incremental expected information are
IDn (θ) = I
D
n (θ) =
n1
σ2
(1 + ex1−θ)−4e2(x1−θ) +
n2
σ2
(1 + ex2−θ)−4e2(x2−θ).
Table 1 provides tail probabilities of MLE θˆn normalized by the four different information measures when the first-stage
sample size is fixed at n1 = 30 and the total sample size is n = {100, 200, 400}. In each scenario, 10,000 data
sets are generated. When normalized by the expected (Fisher) information, MLEs’ tail probabilities are far from the
nominal ones in all situations. Random information measures perform better in all scenarios, and as n increases, the
tail probabilities are closer to nominal ones. When n = 400, the tail probabilities of MLE normalized by random
information are almost the same as the nominal ones.
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Table 2 also provides tail probabilities of MLEs normalized by different information measures, but now the first stage
sample size is n∗1 with total sample size n = {100, 200, 400}. The performance of the observed information does not
change too much when compared with results in Table 1, while other information measures (including the expected
information) perform better. Still random information measures perform better than the Fisher information in all
scenarios. Of course, as n increases, the tail probabilities normalized by all information measures are closer to the
nominal one. When n = 400 and n1 = 30, the tail probabilities obtained with random information measures are rather
close to nominal ones.
Figure 1 shows the integrated absolute difference between the cumulative distribution functions (CDF) of standard
normal distribution and the CDFs of MLE normalized by each of the four information measures when n1 = n∗1. The
integrated absolute difference between the CDFs of the t-distribution with 60 degrees of freedom and the standard
normal distribution is also graphed to provide a sense of scale. One can see that normalizing MLEs with the random
information measures brings them closer to the standard normal than normalizing with the expected information.
Moreover, the observed information performs best in terms of the integrated absolute difference when the total sample
size n is small. Of course, the distribution of MLEs with all normings becomes closer to the standard normal distribution
as n increases.
Table 1: Tail probabilities of the MLE normalized with four different information measures under the logistic-location
model
n1/n Information Measure Left Tail / Right Tail
Nominal 0.005/0.005 0.025/0.025 0.050/0.050 0.100/0.100
i(ξA, θ) 0.005/0.007 0.024/0.032 0.052/0.058 0.104/0.109
30/100 jn(θ) 0.004/0.006 0.023/0.030 0.049/0.055 0.098/0.106
JDn (θ) 0.004/0.007 0.022/0.029 0.047/0.052 0.095/0.103
IDn (θ)/I
D
n (θ) 0.004/0.006 0.022/0.030 0.048/0.053 0.097/0.104
i(ξA, θ) 0.008/0.007 0.030/0.030 0.058/0.056 0.110/0.106
30/200 jn(θ) 0.006/0.006 0.025/0.026 0.051/0.050 0.101/0.099
JDn (θ) 0.006/0.006 0.025/0.025 0.050/0.050 0.099/0.098
IDn (θ)/I
D
n (θ) 0.006/0.006 0.025/0.025 0.051/0.049 0.100/0.098
i(ξA, θ) 0.008/0.006 0.032/0.028 0.058/0.057 0.112/0.108
30/400 jn(θ) 0.006/0.004 0.026/0.024 0.050/0.050 0.102/0.100
JDn (θ) 0.006/0.004 0.027/0.024 0.050/0.049 0.100/0.099
IDn (θ)/I
D
n (θ) 0.006/0.004 0.027/0.024 0.050/0.049 0.102/0.099
Table 2: Tail probabilities of the MLE normalized with four different information measures under the logistic-location
model
n∗1/n Information Measure Left Tail / Right Tail
Nominal 0.005/0.005 0.025/0.025 0.050/0.050 0.100/0.100
i(ξA, θ) 0.013/0.010 0.035/0.035 0.060/0.060 0.111/0.111
17/100 jn(θ) 0.005/0.008 0.025/0.030 0.050/0.055 0.098/0.105
JDn (θ) 0.004/0.008 0.031/0.029 0.054/0.051 0.103/0.099
IDn (θ)/I
D
n (θ) 0.005/0.007 0.030/0.030 0.055/0.054 0.104/0.102
i(ξA, θ) 0.010/0.009 0.031/0.033 0.057/0.061 0.112/0.113
23/200 jn(θ) 0.005/0.006 0.024/0.029 0.047/0.054 0.100/0.105
JDn (θ) 0.009/0.006 0.028/0.028 0.050/0.053 0.101/0.102
IDn (θ)/I
D
n (θ) 0.008/0.006 0.027/0.028 0.050/0.054 0.102/0.104
i(ξA, θ) 0.008/0.006 0.032/0.028 0.058/0.057 0.112/0.108
30/400 jn(θ) 0.006/0.004 0.026/0.024 0.050/0.050 0.102/0.100
JDn (θ) 0.006/0.004 0.027/0.024 0.050/0.049 0.100/0.099
IDn (θ)/I
D
n (θ) 0.006/0.004 0.027/0.024 0.050/0.049 0.102/0.099
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Figure 1: Integrated absolute differences between the cumulative distributions of MLEs (1) normalized by four
information measures and (2) the t-distribution with 60 degrees of freedom, and the cumulative distribution of standard
normal distribution as n increases from 100 to 6000 with n1 = n∗1 under the logistic-location model.
5.1.2 The Logistic-Scale Model
To explore whether the relative performance of different information norms differs between scale and location parameter
estimates, now consider the Logistic-Scale Model:
y = [1 + eθx]−1 + ,  ∼ N(0, σ2), x ∈ [a, b], −∞ < a < b <∞, (10)
with first-stage likelihood Ln1(θ|y11) ∝ exp
{− n12σ2 [y¯1 − (1 + eθx1)−1]2} . Because θ ∈ (0, θ¯), maximizing the
first-stage likelihood function yields the MLE
θˆn1 =

−logit(y¯1)
x1
if y¯1 ∈
(
(1 + eθ¯x)−1, 1/2
)
,
0 if y¯1 ≥ 1/2,
θ¯ if y¯1 ≤ (1 + eθ¯x)−1.
The adaptively selected second-stage dose when x2(θˆ) ∈ [a, b] is
xˆ2 = arg max
{
[ ddθη(x2, θ)]
2|θ=θˆn1
}
,
where [ ddθη(x2, θ)]
2 = x22e
2θx2(1 + eθx2)−4. The equation ddx2
{
[ ddθη(x2, θ)]
2|θ=θˆn1
}
= 0 has no analytic solution
for x2, so we find it using numerical methods. The MLE using all data can be found analytically:
θˆn =
 θ
′
n if θ
′
n ∈ (0, 1/a),
0 if θ
′
n ≤ 0,
1/a if θ
′
n ≥ 1/a,
where θ
′
n maximizes
Ln(θ|y11, . . . , y1,n1 , y21, . . . , y2,n2) ∝ exp
{
− n12σ2 [y¯1 − (1 + eθx1)−1]2 − n22σ2 [y¯2 − (1 + eθx2(y¯1))−1]2
}
.
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The Fisher information is derived numerically because we do not have an explicit function for x2(y¯1). However, we can
still derive the random information measures analytically. The observed information is
jn(θ) =
n1
σ2
x21e
2θx1(1 + eθx1)−4 − n1
σ2
[
y¯1 − (1 + eθx1)−1
]
(1 + eθx1)−3(eθx1 − 1)eθx1x21
+
n2
σ2
x22e
2θx2(1 + eθx2)−4 − n2
σ2
[
y¯2 − (1 + eθx2)−1
]
(1 + eθx2)−3(eθx2 − 1)eθx2x22;
the subject-wise incremental observed information is
JDn (θ) =
n1∑
i=1
[yi − (1 + eθx1)−1]2
σ4
x21e
2θx1(1 + eθx1)−4 +
n∑
i=n1+1
[yi − (1 + eθx2)−1]2
σ4
x22e
2θx2(1 + eθx2)−4;
and the stage-wise and subject-wise incremental expected information are
IDn (θ) = I
D
n (θ) =
n1
σ2
x21e
2θx1(1 + eθx1)−4 +
n2
σ2
x22e
2θx2(1 + eθx2)−4.
Table 3 presents the tail probabilities of the MLE θˆn normalized by these four different information measures under
Model 10. First, comparing with the same scenario in Table 3, we note that the tail probabilities are much farther
from the nominal ones when the first-stage sample size is fixed at n1 = 20 and n = 400. This indicates that the
scale-parameter estimators converge more slowly than the location-parameter estimators. Because estimators perform
rather poorly when n1 is small regarding of their normalizing measure, Table 3 also shows tail probabilities for larger
sample sizes, namely, n1 = 100 and n = {2000, 3000}. In both cases, random information measures perform better
than the expected information. As n increases, the tail probabilities of the MLE normalized by random information
measures are closer to the nominal ones. When n = 3000, the tail probabilities of the MLE normalized by random
information measures are almost identical to nominal ones.
The tail probabilities of MLEs normalized by different information measures when the first stage sample size is n∗1,
and n = {400, 2000, 3000} are presented in Table 4. The performance of random information measures does not
change much when compared with results in Table 3, while the expected information perform better. However, random
information measures still perform as good as the expected information in both n = 2000 and n = 3000 cases. Still, as
n increases, the tail probabilities normalized by all information measures are closer to the nominal one. When n = 3000
and n1 = 434, the tail probabilities obtained with all information measures are rather close to nominal ones.
Figure 2 shows the integrated absolute difference between the cumulative distribution functions (CDFs) of MLE
normalized by the four information measures and the CDF of standard normal distribution when n1 = n∗1. Regarding
the integrated absolute difference between the CDF of t-distribution with 60 degree of freedom and standard normal
distribution as a benchmark, one can see that normalizing MLEs with each information measure brings them closer to
being standard normal as n increases. In addition, the distribution of MLEs normalized by each random information
measure is as close to the standard normal distribution as the one normalized by the expected information. The reason
is that n1 = n∗1 under this model is large enough that the MLE converges to a normal distribution instead of a random
scale mixture of normal distribution.
5.2 The Exponential Regression Model
Now we present and compare the performance of estimators from two-stage adaptive optimal designs under exponential
location and scale models.
5.2.1 The Exponential-Location Model
The Exponential-Location Model,
y = e−x+θ + ,  ∼ N(0, σ2), x ∈ [a, b], −∞ < a < b <∞,
has first-stage MLE
θˆn1 =
 x1 + log y¯1 if y¯1 ∈ (e
−x1 , e−x1+θ¯),
0 if y¯1 ≤ e−x1 ,
θ¯ if y¯1 ≥ e−x1+θ¯.
The adaptively selected second-stage dose is
xˆ2 = arg max[
d
dθη(x2, θ)]
2|θ=θˆn1 , x2 ∈ [a, b];
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Table 3: Tail probabilities of the MLE normalized with four different information measures under the logistic-scale
Model
n1/n Information Measure Left Tail / Right Tail
Nominal 0.005/0.005 0.025/0.025 0.050/0.050 0.100/0.100
i(ξA, θ) 0.010/0.016 0.033/0.156 0.055/0.176 0.098/0.216
30/400 jn(θ) 0.013/0.002 0.041/0.015 0.065/0.034 0.107/0.079
JDn (θ) 0.012/0.001 0.040/0.013 0.063/0.030 0.106/0.073
IDn (θ)/I
D
n (θ) 0.012/0.002 0.040/0.012 0.064/0.031 0.106/0.073
i(ξA, θ) 0.008/0.024 0.030/0.051 0.053/0.074 0.102/0.121
100/2000 jn(θ) 0.009/0.003 0.031/0.020 0.054/0.046 0.106/0.093
JDn (θ) 0.009/0.003 0.031/0.020 0.054/0.045 0.105/0.092
IDn (θ)/I
D
n (θ) 0.009/0.003 0.030/0.020 0.054/0.045 0.106/0.092
i(ξA, θ) 0.007/0.032 0.027/0.049 0.052/0.076 0.100/0.125
100/3000 jn(θ) 0.007/0.004 0.028/0.023 0.053/0.049 0.104/0.101
JDn (θ) 0.007/0.004 0.027/0.022 0.052/0.049 0.104/0.100
IDn (θ)/I
D
n (θ) 0.007/0.004 0.028/0.023 0.053/0.048 0.103/0.100
Table 4: Tail probabilities of the MLE normalized with four different information measures under the logistic-scale
Model
n∗1/n Information Measure Left/Right
Nominal 0.005/0.005 0.025/0.025 0.050/0.050 0.100/0.100
i(ξA, θ) 0.012/<0.001 0.037/0.006 0.063/0.025 0.112/0.072
174/400 jn(θ) 0.013/0.001 0.040/0.011 0.068/0.030 0.116/0.080
JDn (θ) 0.013/0.001 0.038/0.010 0.067/0.028 0.116/0.078
IDn (θ)/I
D
n (θ) 0.013/<0.001 0.040/0.010 0.067/0.029 0.115/0.078
i(ξA, θ) 0.006/0.002 0.028/0.020 0.058/0.045 0.105/0.092
361/2000 jn(θ) 0.007/0.003 0.030/0.020 0.060/0.046 0.107/0.094
JDn (θ) 0.007/0.003 0.030/0.020 0.059/0.046 0.106/0.094
IDn (θ)/I
D
n (θ) 0.007/0.002 0.029/0.020 0.059/0.046 0.106/0.093
i(ξA, θ) 0.007/0.003 0.029/0.020 0.053/0.044 0.102/0.097
434/3000 jn(θ) 0.008/0.003 0.029/0.022 0.054/0.045 0.104/0.097
JDn (θ) 0.007/0.004 0.029/0.022 0.053/0.044 0.103/0.097
IDn (θ)/I
D
n (θ) 0.007/0.003 0.029/0.021 0.053/0.045 0.103/0.097
Note that [ ddθη(x2, θ)]
2 = (e−x2+θ)2 = e2(θ−x2) is maximized at x2 = a, a constant that does not depend on y¯1. So
under this model, if n1/n is small (and provided common regularity conditions hold with η˙ 6= 0, |η˙| < ∞), then
U = σ[η˙(x2, θ)]
−1 in equation (2) is a constant, instead of a random function of y¯1, even if n1 is held fixed while
n→∞. In this case, this procedure is simply two separate designs, instead of two-stage adaptive design. Therefore,√
n(θˆn − θ) d→ N(0, U2) as n2 →∞ with n1 fixed.
5.2.2 The Exponential-Scale Model
Consider
y = e−θx + ,  ∼ N(0, σ2), x ∈ [a, b], −∞ < a < b <∞,
θ = 1. In this model, Lane et al. [14] have the following results: The MLE based on data from first stage is
θˆn1 =

− log y¯1
x1
if y¯1 ∈ (e−x1θ¯, 1),
0 if y¯1 ≥ 1,
θ¯ if y¯1 ≤ e−x1θ¯.
The second stage uses the dose
xˆ2 =
 θˆ
−1
n1 if y¯1 ∈ (e−x1/a, e−x1/b),
b if y¯1 ≥ e−x1/b,
a if y¯1 ≤ e−x1/a.
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Figure 2: Integrated absolute differences between the cumulative distributions of MLEs (1) normalized by four
information measures and (2) the t-distribution with 60 degrees of freedom, and the cumulative distribution of standard
normal distribution as n increases from 100 to 6000 with n1 = n∗1 under the logistic-scale model.
Lane and Flournoy [13] find the average expected information for the Exponential-Scale Model to be
1
n
i(ξA, θ) =
1
σ2
{
w1x
2
1e
−2θx1 + w2piaa2e−2θa + w2pibb2e−2θb
+ w2Ey¯1
[(− log y¯1
x1
)2
e2θx1/ log y¯1I(e−x1/a < y¯1 < e−x1/b)
]}
,
where pia = Φ(
√
n1(e
−x1/a − e−x1θ)/σ) and pib = 1− Φ(√n1(e−x1/b − e−x1θ)/σ). The MLE using all data is
θˆn =
 θ
′
n if θ
′
n ∈ (0, 1/a),
0 if θ
′
n ≤ 0,
1/a if θ
′
n ≥ 1/a,
where θ
′
n maximizes Ln(θ|y11, . . . , y1,n1 , y21, . . . , y2,n2) ∝ exp
{− n12σ2 [y¯1 − e−θx1 ]2 − n22σ2 [y¯2 − e−θx2(y¯1)]2} .
According to functions (4), (5) and (8), the observed information is
jn(θ) =
n1
σ2
x21e
−2θx1 − n1
σ2
(
y¯1 − e−θx1
)
x21e
−θx1 +
n2
σ2
x22e
−2θx2 − n2
σ2
(
y¯2 − e−θx2
)
x22e
−θx2 ;
the subject-wise incremental observed information
JDn (θ) =
n1∑
i=1
[yi − e−θx1 ]2
σ4
x21e
−2θx1 +
n∑
i=n1+1
[yi − e−θx2 ]2
σ4
x22e
−2θx2 ;
and the stage-wise and subject-wise incremental expected information are
IDn (θ) = I
D
n (θ) =
n1
σ2
x21e
−2θx1 +
n2
σ2
x22e
−2θx2 .
Again, we use the random information measures to normalize the MLE θˆn.
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Table 5: Tail probabilities of MLE of scale parameter normalized by different information measures under the
exponential-scale Model
n1/n Information Measure Left Tail / Right Tail
Nominal 0.005/0.005 0.025/0.025 0.050/0.050 0.100/0.100
i(ξA, θ) 0.013/0.037 0.039/0.056 0.068/0.080 0.117/0.128
30/500 jn(θ) 0.009/0.003 0.033/0.018 0.061/0.040 0.108/0.090
JDn (θ) 0.009/0.002 0.033/0.018 0.061/0.039 0.108/0.088
IDn (θ)/I
D
n (θ) 0.009/0.002 0.032/0.017 0.061/0.039 0.108/0.088
i(ξA, θ) 0.012/0.038 0.036/0.060 0.062/0.085 0.114/0.132
30/1000 jn(θ) 0.007/0.003 0.029/0.021 0.055/0.047 0.106/0.094
JDn (θ) 0.007/0.003 0.028/0.020 0.055/0.046 0.104/0.093
IDn (θ)/I
D
n (θ) 0.007/0.003 0.029/0.020 0.055/0.046 0.106/0.093
i(ξA, θ) 0.011/0.037 0.035/0.059 0.062/0.086 0.112/0.132
30/2000 jn(θ) 0.006/0.004 0.028/0.023 0.052/0.048 0.100/0.096
JDn (θ) 0.006/0.004 0.027/0.023 0.050/0.047 0.099/0.096
IDn (θ)/I
D
n (θ) 0.006/0.004 0.027/0.023 0.052/0.048 0.099/0.096
Table 6: Tail probabilities of MLE of scale parameter normalized by different information measures under the
exponential-scale Model
n∗1/n Information Measure Left/Right
Nominal 0.005/0.005 0.025/0.025 0.050/0.050 0.100/0.100
i(ξA, θ) 0.012/0.009 0.038/0.027 0.065/0.052 0.117/0.105
60/500 jn(θ) 0.010/0.003 0.033/0.018 0.060/0.040 0.111/0.096
JDn (θ) 0.010/0.003 0.033/0.017 0.058/0.039 0.110/0.095
IDn (θ)/I
D
n (θ) 0.010/0.003 0.033/0.017 0.060/0.039 0.111/0.094
i(ξA, θ) 0.008/0.007 0.035/0.028 0.060/0.050 0.113/0.100
86/1000 jn(θ) 0.007/0.004 0.031/0.024 0.056/0.046 0.107/0.095
JDn (θ) 0.007/0.004 0.031/0.024 0.055/0.046 0.107/0.095
IDn (θ)/I
D
n (θ) 0.007/0.004 0.031/0.024 0.056/0.046 0.107/0.095
i(ξA, θ) 0.007/0.004 0.030/0.024 0.058/0.049 0.107/0.101
122/2000 jn(θ) 0.005/0.004 0.027/0.022 0.054/0.047 0.103/0.098
JDn (θ) 0.005/0.004 0.027/0.022 0.053/0.046 0.103/0.097
IDn (θ)/I
D
n (θ) 0.005/0.004 0.027/0.022 0.054/0.046 0.107/0.101
Because all information measures perform poorly when n is smaller than 500, we present tail probabilities of
MLE normalized by different information measures when the first-stage sample size is fixed at n1 = 30 and
n = {500, 1000, 2000} in Table 5. In each scenario, 10, 000 data sets are generated. The table shows that MLEs
standardized by random information measures have tail probabilities closer to the normal ones than is obtained using the
expected information for all scenarios. All the random norms have similar convergence rates. When n = 2000, the tail
probabilities of MLE normalized by random information measures are almost the same as nominal ones. Furthermore,
recall that the standard normal limit is not obtained by normalizing the MLE using the expected information.
Table 6 shows tail probabilities of MLEs normalized by different information measures when the first stage sample
size is n1 = n∗1 and n = {500, 1000, 2000}. Note that the performance using random information measures does not
change much from what is shown in table 5, while the expected information performs better. When n = 2000, all
random information measures perform well on normalizing MLE.
Figure 3 shows MLEs normalized by random information measures are closer to standard normal than those normalized
by the expected information in terms of integrated absolute difference as expected. Additionally, the observed
information still performs best when the total sample size n is small. And as n increases, MLE with all information
measures is closer to standard normal distribution.
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Figure 3: Integrated absolute differences between the cumulative distributions of MLEs (1) normalized by four
information measures and (2) the t-distribution with 60 degree of freedom, and the cumulative distribution of standard
normal distribution as n increases from 100 to 6000 with n1 = n∗1 under the exponential-scale model.
6 Discussion
A major motivation for this work was the finding that using the Fisher information to normalize the MLE (following
a two-stage optimal adaptive design under nonlinear regression models with independent normal errors) produces a
normal variance mixture limiting distribution instead of a normal limit when the first stage sample size is held fixed
[[13]]. Although they found the asymptotic distribution of the MLE in the case of an exponential mean function, their
derivation is not generalizable. This paper follows up on the comment by Barndorff-Nielsen and Sørensen [2] that
replacing the Fisher information with random norms can yield normal limits. We show how this is done using the
Generalized Cramér-Slutzky theorem in the situation studied by Lane and Flournoy [13].
We also establish this result in the same situation. That is, we derived the observed, incremental expected and
observed information measures in the case of a two-stage adaptive design under a general nonlinear regression model
with conditionally independent normal errors and proved that using them to norm the MLE yields standard normal
distributions when the first sample size is fixed and the second stage sample size is large.
We illustrate these findings assuming logistic and exponential mean functions, and compare the estimation performance
using the three random information measures with the Fisher information norming. We found better performance using
the observed information than using other norms, including the Fisher information under both models.
Additionally, we show that larger sample sizes are required to obtain normal tail probabilities for the scale parameter
than for the location parameter under the logistic model. Moreover, the location parameter under the logistic model
converges faster than the scale parameter under the exponential model.
It is important to recall from Lane and Flournoy [13] that the independence of U and Z in (2) results from the
independence of the sample mean and standard deviation in the normal error distribution of model (1). The consequences
of changing the error distribution need to be investigated.
A variety of adaptive methods are used in clinical trials, including, for example, enrichment designs, early stopping for
toxicity and/or efficacy, and sample size re-estimation. We plan to explore whether the methodology presented in this
paper is applicable in some situations following these adaptive methods as well.
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